Anti-inflammatory and corticosteroid-enhancing actions of vitamin D in monocytes of patients with steroid-resistant and those with steroid-sensitive asthma.

[1]  C. Hawrylowicz,et al.  Enhanced production of IL-17A in patients with severe asthma is inhibited by 1α,25-dihydroxyvitamin D3 in a glucocorticoid-independent fashion. , 2013, The Journal of allergy and clinical immunology.

[2]  M. Holick,et al.  Vitamin D for health: a global perspective. , 2013, Mayo Clinic proceedings.

[3]  D. Leung,et al.  Vitamin D Enhances Glucocorticoid Action in Human Monocytes , 2013, The Journal of Biological Chemistry.

[4]  P. Barnes.  Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease. , 2013, The Journal of allergy and clinical immunology.

[5]  J. Cidlowski,et al.  Exploring the molecular mechanisms of glucocorticoid receptor action from sensitivity to resistance. , 2013, Endocrine development.

[6]  K. Raza,et al.  Availability of 25-Hydroxyvitamin D3 to APCs Controls the Balance between Regulatory and Inflammatory T Cell Responses , 2012, The Journal of Immunology.

[7]  M. Lester.  Steroid Requirements and Immune Associations With Vitamin D Are Stronger in Children Than Adults With Asthma , 2012, Pediatrics.

[8]  J. Drazen.  Asthma: the paradox of heterogeneity. , 2012, The Journal of allergy and clinical immunology.

[9]  D. Riches,et al.  Vitamin D Inhibits Monocyte/Macrophage Proinflammatory Cytokine Production by Targeting MAPK Phosphatase-1 , 2012, The Journal of Immunology.

[10]  Jonathan D. Campbell,et al.  Asthma outcomes: healthcare utilization and costs. , 2012, The Journal of allergy and clinical immunology.

[11]  L. Jackson,et al.  Usefulness of PBMCs to predict clinical response to corticosteroids in asthmatic patients. , 2012, The Journal of allergy and clinical immunology.

[12]  M. Hewison.  Antibacterial effects of vitamin D , 2011, Nature Reviews Endocrinology.

[13]  Christine L. Taylor,et al.  Dietary Reference Intakes for Calcium and Vitamin D , 2016, Pediatric Clinical Practice Guidelines & Policies.

[14]  J. Brehm,et al.  Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study. , 2010, The Journal of allergy and clinical immunology.

[15]  James R Murphy,et al.  Decreased serum vitamin D levels in children with asthma are associated with increased corticosteroid use. , 2010, The Journal of allergy and clinical immunology.

[16]  E. R. Sutherland,et al.  Vitamin D levels, lung function, and steroid response in adult asthma. , 2010, American journal of respiratory and critical care medicine.

[17]  J. Saklatvala,et al.  Glucocorticoid Regulation of Mouse and Human Dual Specificity Phosphatase 1 (DUSP1) Genes , 2009, The Journal of Biological Chemistry.

[18]  J. Skripak.  Chromosome 17q21 Gene Variants Are Associated With Asthma and Exacerbations But Not Atopy in Early Childhood , 2009, Pediatrics.

[19]  S. Nordeen,et al.  Estrogen Inhibits Glucocorticoid Action via Protein Phosphatase 5 (PP5)-mediated Glucocorticoid Receptor Dephosphorylation* , 2009, The Journal of Biological Chemistry.

[20]  Carlos A Camargo,et al.  Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. , 2009, Archives of internal medicine.

[21]  David W H Riches,et al.  Corticosteroid-resistant asthma is associated with classical antimicrobial activation of airway macrophages. , 2008, The Journal of allergy and clinical immunology.

[22]  Claudio N. Cavasotto,et al.  Glucocorticoid receptor phosphorylation differentially affects target gene expression. , 2008, Molecular endocrinology.

[23]  Glenville Jones.  Pharmacokinetics of vitamin D toxicity. , 2008, The American journal of clinical nutrition.

[24]  J. Adams,et al.  Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity , 2008, Nature Clinical Practice Endocrinology &Metabolism.

[25]  Richard J Martin,et al.  Airway remodeling and lack of bronchodilator response in steroid-resistant asthma. , 2007, The Journal of allergy and clinical immunology.

[26]  A. Litonjua,et al.  Is vitamin D deficiency to blame for the asthma epidemic? , 2007, The Journal of allergy and clinical immunology.

[27]  N. Moore,et al.  Steroid receptor phosphorylation: a key modulator of multiple receptor functions. , 2007, Molecular endocrinology.

[28]  M. Holick.  Vitamin D deficiency. , 2007, The New England journal of medicine.

[29]  S. Keyse,et al.  Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases , 2007, Oncogene.

[30]  A. Litonjua,et al.  Maternal intake of vitamin D during pregnancy and risk of recurrent wheeze in children at 3 y of age. , 2007, The American journal of clinical nutrition.

[31]  Richard J Martin,et al.  Increased glucocorticoid receptor beta alters steroid response in glucocorticoid-insensitive asthma. , 2006, American journal of respiratory and critical care medicine.

[32]  I. Adcock,et al.  Update on glucocorticoid action and resistance. , 2006, The Journal of allergy and clinical immunology.

[33]  M. Dallman,et al.  Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. , 2005, The Journal of clinical investigation.

[34]  Raj Kumar,et al.  Gene regulation by the glucocorticoid receptor: Structure:function relationship , 2005, The Journal of Steroid Biochemistry and Molecular Biology.

[35]  Sungtae Kim,et al.  1,25‐Dihydroxyvitamin D3 Stimulates Cyclic Vitamin D Receptor/Retinoid X Receptor DNA‐Binding, Co‐activator Recruitment, and Histone Acetylation in Intact Osteoblasts , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[36]  M. Garabedian,et al.  Modulation of Glucocorticoid Receptor Function via Phosphorylation , 2004, Annals of the New York Academy of Sciences.

[37]  J. Travers,et al.  Cytokine Milieu of Atopic Dermatitis, as Compared to Psoriasis, Skin Prevents Induction of Innate Immune Response Genes 1 , 2003, The Journal of Immunology.

[38]  A. Clark.  MAP kinase phosphatase 1: a novel mediator of biological effects of glucocorticoids? , 2003, The Journal of endocrinology.

[39]  Stephen C Lazarus,et al.  Banks CORTICOSTEROIDS FOR PERSISTENT ASTHMA SIGNIFICANT VARIABILITY IN RESPONSE TO INHALED Services , 2022 .

[40]  William M Vollmer,et al.  Association of asthma control with health care utilization: a prospective evaluation. , 2002, American journal of respiratory and critical care medicine.

[41]  O. Kassel,et al.  Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP‐1 , 2001, The EMBO journal.

[42]  E. Juniper,et al.  Measuring asthma control. Clinic questionnaire or daily diary? , 2000, American journal of respiratory and critical care medicine.

[43]  S. Wenzel,et al.  Increased T-cell receptor vbeta8+ T cells in bronchoalveolar lavage fluid of subjects with poorly controlled asthma: a potential role for microbial superantigens. , 1999, The Journal of allergy and clinical immunology.

[44]  J. Lafitte,et al.  Increased glucocorticoid receptor beta in airway cells of glucocorticoid-insensitive asthma. , 1999, American journal of respiratory and critical care medicine.

[45]  P. Barnes,et al.  Anti-inflammatory actions of glucocorticoids: molecular mechanisms. , 1998, Clinical science.

[46]  S. Szefler,et al.  Difficult-to-control asthma: clinical characteristics of steroid-insensitive asthma. , 1998, The Journal of allergy and clinical immunology.